We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$17B
AUM Growth
-$1.5B
Cap. Flow
-$3.24B
Cap. Flow %
-19.02%
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 27.35%
2 Financials 13.45%
3 Industrials 10.46%
4 Healthcare 10.18%
5 Communication Services 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUBO icon
1426
FuboTV Inc
FUBO
$296M
$801K ﹤0.01%
17,296
JBGS
1427
JBG SMITH
JBGS
$692M
$801K ﹤0.01%
46,307
-5,970
-11% -$97.2K
HCI icon
1428
HCI Group
HCI
$2.32B
$801K ﹤0.01%
5,263
+298
+6% +$45.8K
XHR
1429
Xenia Hotels & Resorts
XHR
$1.76B
$799K ﹤0.01%
63,600
-215
-0.3% -$2.46K
GTX icon
1430
Garrett Motion
GTX
$5.35B
$798K ﹤0.01%
+75,916
New +$764K
RSI icon
1431
Rush Street Interactive
RSI
$2.85B
$798K ﹤0.01%
53,543
+6,865
+15% +$85.2K
NVEE
1432
DELISTED
NV5 Global
NVEE
$795K ﹤0.01%
34,427
ACMR icon
1433
ACM Research
ACMR
$5.65B
$795K ﹤0.01%
30,677
SONO icon
1434
Sonos
SONO
$1.96B
$794K ﹤0.01%
73,491
CLDX icon
1435
Celldex Therapeutics
CLDX
$3.35B
$794K ﹤0.01%
39,004
FA icon
1436
First Advantage
FA
$3.81B
$793K ﹤0.01%
47,769
+11,459
+32% +$185K
PL icon
1437
Planet Labs
PL
$8.82B
$791K ﹤0.01%
129,720
+5,072
+4% +$20.7K
MLKN icon
1438
MillerKnoll
MLKN
$1.62B
$790K ﹤0.01%
40,655
-281
-0.7% -$4.79K
VITL icon
1439
Vital Farms
VITL
$498M
$788K ﹤0.01%
20,451
+699
+4% +$23.6K
IRON icon
1440
Disc Medicine
IRON
$3.07B
$787K ﹤0.01%
14,854
+1,400
+10% +$65.8K
EVH icon
1441
Evolent Health
EVH
$527M
$786K ﹤0.01%
69,829
PD icon
1442
PagerDuty
PD
$932M
$785K ﹤0.01%
51,347
-299
-0.6% -$4.64K
OCUL icon
1443
Ocular Therapeutix
OCUL
$2.22B
$780K ﹤0.01%
84,066
-9,331
-10% -$73K
TCBK icon
1444
TriCo Bancshares
TCBK
$1.86B
$778K ﹤0.01%
19,226
TVTX icon
1445
Travere Therapeutics
TVTX
$5.79B
$778K ﹤0.01%
52,578
+3,290
+7% +$54.5K
TPB icon
1446
Turning Point Brands
TPB
$1.73B
$778K ﹤0.01%
10,266
ROG icon
1447
Rogers Corp
ROG
$2.46B
$773K ﹤0.01%
11,286
CTS icon
1448
CTS Corp
CTS
$1.79B
$771K ﹤0.01%
18,100
BHVN icon
1449
Biohaven
BHVN
$2.24B
$770K ﹤0.01%
54,560
+3,499
+7% +$62.4K
AMRX icon
1450
Amneal Pharmaceuticals
AMRX
$6.02B
$768K ﹤0.01%
94,937

Similar funds

MetLife Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.

  • MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
  • MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
  • MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
  • MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
  • MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
  • MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.